Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8 Ubunyulu ≥99.5% (HPLC) Sitagliptin Phosphate Monohydrate Intermediate
Ubonelelo ngeSitagliptin Phosphate Monohydrate Eziyeleleneyo neziPhakathi:
I-Sitagliptin API CAS 486460-32-6
I-Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
I-Sitagliptin Triazole Hydrochloride CAS 762240-92-6
I-Sitagliptin Phosphate Monohydrate ePhakathi CAS 486460-21-3
Igama leMchiza | I-Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid |
Izithethantonye | (R)-Sitagliptin N-Boc-Acid Ukungcola |
Inombolo yeCAS | 486460-00-8 |
Inombolo yeCAT | RF-PI1192 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C15H18F3NO4 |
Ubunzima beMolekyuli | 333.31 |
Indawo yokunyibilika | 136.0 ~ 138.0℃ |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Ukuchongwa yi-HPLC | Ixesha lokuGcinwa kweSampuli lihambelana noMgangatho weReferensi |
Ilahleko ekomisweni | ≤0.50% |
Uthuthu lweSulfate | ≤0.50% |
Iintsimbi ezinzima | <20ppm |
Isomer | ≤0.50% |
Izinto ezinxulumeneyo | |
Ukungcola A | ≤0.50% |
Nakuphi na Okunye Ukungcola Okukodwa | ≤0.50% |
Ukungcola ngokupheleleyo | ≤0.50% |
Ubunyulu | ≥99.5% (HPLC) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi weSitagliptin Phosphate Monohydrate (CAS: 654671-77-9) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-Boc-(R)-3-Amino-4- (2,4,5-Trifluoro-Phenyl)-I-Butyric Acid (i-CAS: 486460-00-8) yinto ebalulekileyo ephakathi ukulungiselela i-sitagliptin.I-Sitagliptinphosphate yi-inhibitor yokuqala ye-dipeptidase -IV (DPP-4) evunywe yi-FDA ngo-2006. Isetyenziselwa unyango lwe-type II diabetes mellitus.Inesiphumo esicacileyo se-hypoglycemic xa isetyenziswa yodwa okanye idityaniswe ne-metformin kunye ne-pioglitazone, kwaye kukhuselekile ukuyithatha, inyamezeleke kakuhle, kunye neempendulo ezimbalwa ezibi.Ngo-Agasti ka-2009, ichiza lamkelwa yiManyano yaseYurophu njengechiza lokuqala kunyango lwe-2 seswekile.Emva kwe-2011, elinye emva kwelinye ilizwe livumile ukudibanisa i-sitagliptin phosphate kunye ne-alpha glycosidase inhibitors okanye i-insulin.I-Sitagliptin phosphate yeyokuqala i-FDA-evunyiweyo yi-dipeptidyl peptidase-IV inhibitor ukuba isetyenziswe kunyango lwe-2 yeswekile ukuza kuthi ga ngoku, phantsi kwegama lorhwebo i-Januvia.